HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts

Neoplasia (United States)

Volumn 15, Issue 3, 2013, Pages 328-334

  Mohlin, Sofie ^a   Hamidian, Arash ^a   Påhlman, Sven ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; NEUROMODULIN; SOMATOMEDIN B;

ADRENERGIC SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMAFFIN CELL; DOWN REGULATION; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROBLAST; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84874587449     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121706     Document Type: Article

References (24)

1. Anderson DJ (1993). Molecular control of cell fate in the neural crest: the sympathoadrenal lineage. Annu Rev Neurosci 16, 129-158.
2. Hoehner JC, Gestblom C, Hedborg F, Sandstedt B, Olsen L, and Påhlman S (1996). A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 75, 659-675.
3. Fredlund E, Ringner M, Maris JM, and Påhlman S (2008). High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci USA 105, 14094-14099.
4. Jögi A, Øra I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, Axelson H, and Påhlman S (2002). Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 99, 7021-7026.
5. Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49, 6449-6465.
6. Semenza GL (2012). Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-408.
7. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, Pietras A, Vallon-Christersson J, Borg Å, Gradin K, et al. (2006). Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma: HIF-2α promotes an aggressive phenotype. Cancer Cell 10, 413-423.
8. Noguera R, Fredlund E, Piqueras M, Pietras A, Beckman S, Navarro S, and Påhlman S (2009). HIF-1α and HIF-2α are differentially regulated in vivo in neuroblastoma: high HIF-1α correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res 15, 7130-7136.
9. Pietras A, Gisselsson D, Øra I, Noguera R, Beckman S, Navarro S, and Påhlman S (2008). High levels of HIF-2α highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 214, 482-488.
10. Nilsson H, Jögi A, Beckman S, Harris AL, Poellinger L, and Påhlman S (2005). HIF-2α expression in human fetal paraganglia and neuroblastoma: relation to sympathetic differentiation, glucose deficiency, and hypoxia. Exp Cell Res 303, 447-456.
11. Tian H, Hammer RE, Matsumoto AM, Russell DW, and McKnight SL (1998). The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12, 3320-3324.
12. Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, and Pacak K (2012). Somatic HIF2A gain-offunction mutations in paraganglioma with polycythemia. N Engl J Med 367, 922-930.
13. Huang LE, Gu J, Schau M, and Bunn HF (1998). Regulation of hypoxiainducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95, 7987-7992.
14. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, and Poellinger L (1999). Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J Biol Chem 274, 6519-6525.
15. Löfstedt T, Fredlund E, Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L, and Påhlman S (2007). Hypoxia inducible factor-2α in cancer. Cell Cycle 6, 919-926.
16. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC, and Påhlman S (1995). IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 146, 833-847.
17. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, and Speleman F (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034.
18. Khanna C, Jaboin JJ, Drakos E, Tsokos M, and Thiele CJ (2002). Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In Vivo 16, 77-85.
19. Fredlund E, Ovenberger M, Borg K, and Påhlman S (2008). Transcriptional adaptation of neuroblastoma cells to hypoxia. Biochem Biophys Res Commun 366, 1054-1060.
20. Lin Q, Cong X, and Yun Z (2011). Differential hypoxic regulation of hypoxiainducible factors 1α and 2α. Mol Cancer Res 9, 757-765.
21. Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, and Simon MC (2010). Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1α. Cancer Res 70, 10351-10361.
22. Strachan T, Lindsay S, and Wilson DI (1997). Molecular Genetics of Early Human Development. BIOS Scientific Publishers Ltd, Oxford, United Kingdom.
23. Hoehner JC, Hedborg F, Eriksson L, Sandstedt B, Grimelius L, Olsen L, and Pahlman S (1998). Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 78, 29-45.
24. Cushing H and Wolbach SB (1927). The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol 3, 203-216.7.